Selyutina Olga Yu, Mastova Anna V, Polyakov Nikolay E
Institute of Chemical Kinetics and Combustion, Institutskaya St., 3, 630090 Novosibirsk, Russia.
Membranes (Basel). 2023 Jan 3;13(1):61. doi: 10.3390/membranes13010061.
Anthracycline antibiotics, e.g., doxorubicin, daunomycin, and other anthraquinones, are an important family of antitumor agents widely used in chemotherapy, which is currently the principal method for treating many malignancies. Thus, development of improved antitumor drugs with enhanced efficacy remains a high priority. Interaction of anthraquinone-based anticancer drugs with cell membranes attracts significant attention due to its importance in the eventual overcoming of multidrug resistance (MDR). The use of drugs able to accumulate in the cell membrane is one of the possible ways of overcoming MDR. In the present work, the aspects of interaction of anthraquinone 2-phenyl-4-(butylamino)naphtho[2,3-h]quinoline-7,12-dione) (Q1) with a model membrane were studied by means of NMR and molecular dynamics simulations. A fundamental shortcoming of anthracycline antibiotics is their high cardiotoxicity caused by reactive oxygen species (ROS). The important feature of Q1 is its ability to chelate transition metal ions responsible for ROS generation in vivo. In the present study, we have shown that Q1 and its chelating complexes penetrated into the lipid membrane and were located in the hydrophobic part of the bilayer near the bilayer surface. The chelate complex formation of Q1 with metal ions increased its penetration ability. In addition, it was found that the interaction of Q1 with lipid molecules could influence lipid mobility in the bilayer. The obtained results have an impact on the understanding of molecular mechanisms of Q1 biological activity.
蒽环类抗生素,如阿霉素、柔红霉素和其他蒽醌类化合物,是一类重要的抗肿瘤药物,广泛应用于化疗,而化疗目前是治疗多种恶性肿瘤的主要方法。因此,开发疗效更高的改进型抗肿瘤药物仍然是重中之重。基于蒽醌的抗癌药物与细胞膜的相互作用因其在最终克服多药耐药性(MDR)方面的重要性而备受关注。使用能够在细胞膜中积累的药物是克服MDR的可能途径之一。在本研究中,通过核磁共振(NMR)和分子动力学模拟研究了蒽醌2-苯基-4-(丁基氨基)萘并[2,3-h]喹啉-7,12-二酮(Q1)与模型膜的相互作用。蒽环类抗生素的一个基本缺点是它们会因活性氧(ROS)导致高心脏毒性。Q1的重要特性是它能够螯合体内负责产生ROS的过渡金属离子。在本研究中,我们已经表明Q1及其螯合配合物能够穿透脂质膜,并位于双层膜靠近表面的疏水部分。Q1与金属离子形成螯合配合物增加了其穿透能力。此外,还发现Q1与脂质分子的相互作用会影响双层膜中脂质的流动性。所得结果对理解Q1生物活性的分子机制有重要意义。